Menu

Search

  |   Business

Menu

  |   Business

Search

Nestle Reports Sales Dip Amid Price Hikes

Nestle is ramping up its integration strategy for its Health Science's vitamins, minerals, and supplements business, expecting significant growth in the latter half.

Nestle, the titan behind beloved brands like KitKat and Nescafe, has encountered a setback as it reports a decrease in sales following price hikes across its range of packaged foods. The first quarter of 2024 saw the company's sales falter, particularly in North America, marking a 5.9% drop internationally to 22.1 billion Swiss Francs (£19.4 billion) compared to the previous year.

SkyNews noted that this decline comes amid an overall 3.4% price increase globally, with Europe facing a sharper rise of 4.6%.

Key Product Performance

Despite the gloom, there are silver linings, with the Purina PetCare range standing out as a strong growth driver for the quarter. However, this was not enough to counterbalance the decline in drink sales, including the Coffee Mate brand, and a slump in the nutrition and supplements sector due to supply chain challenges.

Industry-Wide Challenges

Rising costs across the packaged goods industry are attributed to the lingering effects of the COVID-19 pandemic and the geopolitical tensions following Russia's invasion of Ukraine. Amid these challenges, Nestle's organic sales, disregarding currency and acquisition impacts, saw a modest 1.4% increase, falling short of the anticipated 2.9% growth.

Management's Perspective

According to Reuters, Jean-Philippe Bertschy from Vontobel labeled the performance as lacking inspiration, suggesting the results could unsettle investors hoping for a positive turn following competitors' outcomes. Despite this, Nestle's CEO, Mark Schneider, remains optimistic, anticipating a "strong rebound" in the second quarter driven by a surge in innovation and commercial efforts, particularly within the North American frozen food segment.

Nestle is ramping up its integration strategy for Health Science's vitamins, minerals, and supplements business, expecting significant growth in the latter half. The company maintains an organic sales growth forecast of around 4% for 2024, alongside a moderate improvement in its underlying trading profit margin, signaling confidence in its strategic initiatives moving forward.

Photo: PR Newswire

  • Market Data
Close

Welcome to EconoTimes

Sign up for daily updates for the most important
stories unfolding in the global economy.